Mehrdad Shamloo

Title: The Innovative Contributions of Mehrdad Shamloo

Introduction

Mehrdad Shamloo is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of neurological disorders. His work focuses on innovative methods that can potentially change the way ischemic strokes are diagnosed and treated.

Latest Patents

Mehrdad Shamloo holds a patent for a method of diagnosing ischemic stroke via UCP-2 detection. This invention identifies a gene whose product provides a protective effect against neurological disorders or neuronal injuries. The patent outlines methods for diagnosing or assessing an individual's susceptibility to neuronal injuries such as strokes. Furthermore, it provides therapeutic methods for treating patients and prophylactic treatments for individuals at risk of various neurological disorders. The invention also describes screening methods for identifying agents that can be administered to treat individuals who have suffered or are at risk of suffering from such disorders or injuries.

Career Highlights

Currently, Mehrdad Shamloo is associated with Agy Therapeutics, Inc., where he continues to advance his research and innovations. His work is pivotal in developing new diagnostic and therapeutic strategies for neurological conditions.

Collaborations

Mehrdad has collaborated with several professionals in his field, including Mirella Gonzalez-Zulueta and Kc McFarland. These collaborations enhance the research and development efforts at Agy Therapeutics, Inc.

Conclusion

In summary, Mehrdad Shamloo's innovative work in diagnosing and treating neurological disorders has the potential to significantly impact medical practices. His contributions are vital in the ongoing quest to improve patient outcomes in the field of neurology.